“…Over the past 20 years, influenza B viruses have caused frequent epidemics in humans, as have the H1 and H3 subtypes of influenza A viruses. Although influenza B viruses are generally considered less virulent than influenza A viruses, recent studies have demonstrated a substantial clinical impact attributable to influenza B viruses that were shown to cause severe respiratory symptoms as well as central nervous system diseases. − While there are also no antigenically distinguishable subtypes for influenza B viruses based on the surface antigens, two genetically and antigenically distinct lineages of influenza B viruses, represented by the reference strains B/Victoria/2/87 (Victoria) and B/Yamagata/16/1988 (Yamagata), have co-circulated in humans since at least 1983. − Recent advances in antiviral chemotherapy and the ever-present potential of pandemic influenza emphasize the importance of accurate and timely diagnostic techniques. − Moreover, influenza resembles many other respiratory diseases (such as severe acute respiratory syndrome, SARS) and infections caused by many biothreat agents (such as Bacillus anthracis , Yersinia pestis , Botulinum toxin, etc.) in initial symptoms (sudden onset of high fever, headache, muscle pain, severe malaise, etc.).…”